Aug 2026· Ageing Research Reviews· Vol 121, pp.
103288
· 0 citations· 361 references
Medicine
TL;DR
Findings support a systems-level framework in which selected nutraceuticals may influence multiple nodes of retinal stress biology, although clinical validation remains limited.
Abstract
Retinal neurodegenerative diseases, such as age-related macular degeneration, diabetic retinopathy, glaucoma, and inherited retinal dystrophies, are major causes of irreversible vision loss worldwide. Although they originate from different causes, these disorders increasingly appear to share a network of cellular stress pathways, including impaired mitochondrial function, oxidative stress, endoplasmic reticulum proteostasis collapse, chronic neuroinflammation, epigenetic dysregulation, and activation of regulated cell death pathways. The interactions among these processes create an integrated stress network that gradually disrupts retinal homeostasis and promotes neuronal degeneration, which explains the failure of therapies targeting single molecular pathways. Nutraceutical compounds found in food are gaining interest as potential agents to support retinal health because many exhibit pleiotropic biological activities that influence mitochondrial function, inflammatory signaling, antioxidant defenses, and transcriptional regulation. Herein, we consolidate knowledge of the molecular mechanisms underlying retinal neurodegeneration and how major classes of nutraceuticals (polyphenols, carotenoids, omega-3 fatty acids, and metabolic modulators) may interact with these pathways. We also discuss key translational challenges in developing therapies, including poor bioavailability and differences between human phenotypes and model systems. Additionally, we highlight emerging concepts such as microbiome-dependent metabolism of nutraceuticals, personalized nutrition strategies, and advanced ocular drug-delivery technologies. Collectively, these findings support a systems-level framework in which selected nutraceuticals may influence multiple nodes of retinal stress biology, although clinical validation remains limited.
Current evidence represents the microbiota–mitochondria axis as a one of the promising mechanistic and therapeutic targets for neurodegenerative and ocular diseases, however, most therapeutic evidence discussed in this review is derived from preclinical studies, with relatively limited clinical validation.
Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani et al.· Frontiers in Pharmacology· 0 citations
Findings support the concept that antioxidant and anti-inflammatory pathways constitute a unifying framework linking aging to chronic disease progression and promote healthy aging.
R. Trigueiro, Liz Oliveira, P. Newman· Advances in Geriatric Medici...· 0 citations
This review critically synthesizes the cytoprotective roles, evidence boundaries, translational challenges, and future directions of Nrf2/HO-1 signaling in RNDs, organized around retinal cell types, redox homeostasis-related injury mechanisms, disease-specific evidence, and intervention strategies.
Metabolic disorders and neurodegenerative diseases have emerged as a set of interrelated disorders caused by inflammatory processes, oxidative stress, mitochondrial impairment and disruption of cellular signalling mechanisms. Metabolic disorders like obesity and type 2 diabetes, along with neurodegenerative diseases su...
R. Keerthivasan, R. Sudarshan· Trends in Current Biology· 0 citations
Diabetic Kidney Disease (DKD), a prevalent microvascular complication of diabetes mellitus, represents the leading cause of end-stage renal disease worldwide. Its pathogenesis is multifactorial, involving metabolic disturbances, oxidative stress, inflammatory responses, and notably, mitochondrial dysfunction. Mitochond...
Yun-Zhou Wu, Jun-Wei Gao, Jia-Zhe Lin et al.· Mini-Reviews in Medical Chem...· 0 citations
This review proposes mitochondrial-ferroptotic crosstalk as a unifying mechanistic axis associating retinal, renal, and neural complications in diabetes, and identifies mitochondrial-ferroptotic crosstalk as a key pathogenic mechanism and therapeutic opportunity to mitigate multi-organ complications in diabetes.
Satyam Yadav, Issac V. Cherian, Akansha Sharma et al.· Mitochondrion (Amsterdam. Pr...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.